These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1284814)
1. Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1. Haidar M; Seddiki N; Gluckman JC; Gattegno L Glycoconj J; 1992 Dec; 9(6):315-23. PubMed ID: 1284814 [TBL] [Abstract][Full Text] [Related]
2. Mannosyl/N-acetyl-beta-D-glucosaminyl binding properties of the envelope glycoprotein of human immunodeficiency virus type 2. Haïdar M; Gluckman JC; Gattegno L Glycobiology; 1992 Oct; 2(5):429-35. PubMed ID: 1281021 [TBL] [Abstract][Full Text] [Related]
3. alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans. Rabehi L; Ferriere F; Saffar L; Gattegno L Glycoconj J; 1995 Feb; 12(1):7-16. PubMed ID: 7795416 [TBL] [Abstract][Full Text] [Related]
4. Interactions of HIV-1 and HIV-2 envelope glycoproteins with sulphated polysaccharides and mannose-6-phosphate. Mbemba E; Gluckman JC; Gattegno L Glycobiology; 1994 Feb; 4(1):13-21. PubMed ID: 8186546 [TBL] [Abstract][Full Text] [Related]
5. The interaction of a glycosaminoglycan, heparin, with HIV-1 major envelope glycoprotein. Mbemba E; Czyrski JA; Gattegno L Biochim Biophys Acta; 1992 Dec; 1180(2):123-9. PubMed ID: 1281430 [TBL] [Abstract][Full Text] [Related]
6. N-Acetyl-beta-D-glucosaminyl-binding properties of the envelope glycoprotein of human immunodeficiency virus type 1. Gattegno L; Sadeghi H; Saffar L; Bladier D; Clerget-Raslain B; Gluckman JC; Bahraoui E Carbohydr Res; 1991 Jun; 213():79-93. PubMed ID: 1682045 [TBL] [Abstract][Full Text] [Related]
7. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1). Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938 [TBL] [Abstract][Full Text] [Related]
8. Molecular interaction between HIV-1 major envelope glycoprotein and dextran sulfate. Mbemba E; Chams V; Gluckman JC; Klatzmann D; Gattegno L Biochim Biophys Acta; 1992 Jan; 1138(1):62-7. PubMed ID: 1371075 [TBL] [Abstract][Full Text] [Related]
9. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein. Fenouillet E; Gluckman JC J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778 [TBL] [Abstract][Full Text] [Related]
10. The role of calcium and N-linked glycans in the oligomerization and carbohydrate binding properties of human immunodeficiency virus external envelope glycoprotein. Haidar M; Seddiki N; Gluckman JC; Gattegno L Glycoconj J; 1994 Apr; 11(2):73-9. PubMed ID: 7804009 [TBL] [Abstract][Full Text] [Related]
11. Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes. Seddiki N; Rabehi L; Benjouad A; Saffar L; Ferriere F; Gluckman JC; Gattegno L Glycobiology; 1997 Dec; 7(8):1229-36. PubMed ID: 9455924 [TBL] [Abstract][Full Text] [Related]
12. gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing. Merkle RK; Helland DE; Welles JL; Shilatifard A; Haseltine WA; Cummings RD Arch Biochem Biophys; 1991 Oct; 290(1):248-57. PubMed ID: 1898096 [TBL] [Abstract][Full Text] [Related]
13. Conglutinin binds the HIV-1 envelope glycoprotein gp 160 and inhibits its interaction with cell membrane CD4. Andersen O; Sørensen AM; Svehag SE; Fenouillet E Scand J Immunol; 1991 Jan; 33(1):81-8. PubMed ID: 1996409 [TBL] [Abstract][Full Text] [Related]
14. Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva. Su H; Boackle RJ Mol Immunol; 1991 Aug; 28(8):811-7. PubMed ID: 1875953 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of human immunodeficiency virus infection of CD4+ cells by CD4-free glycopeptides from monocytic U937 cells. Mbemba E; Carré V; Atemezem A; Saffar L; Gluckman JC; Gattegno L AIDS Res Hum Retroviruses; 1996 Jan; 12(1):47-53. PubMed ID: 8825618 [TBL] [Abstract][Full Text] [Related]
16. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. Fenouillet E; Miquelis R; Drillien R Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025 [TBL] [Abstract][Full Text] [Related]
17. Properties of HIV membrane reconstituted from its recombinant gp160 envelope glycoprotein. Cornet B; Decroly E; Thines-Sempoux D; Ruysschaert JM; Vandenbranden M AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1823-31. PubMed ID: 1457195 [TBL] [Abstract][Full Text] [Related]
18. Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network. Gorse GJ; Frey SE; Patel G; Newman FK; Belshe RB Vaccine; 1994 Aug; 12(10):912-8. PubMed ID: 7975833 [TBL] [Abstract][Full Text] [Related]
19. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans. Bahraoui E; Benjouad A; Guetard D; Kolbe H; Gluckman JC; Montagnier L AIDS Res Hum Retroviruses; 1992 May; 8(5):565-73. PubMed ID: 1515210 [TBL] [Abstract][Full Text] [Related]
20. Involvement of the HIV-1 external envelope glycoprotein 120 (gp120) C2 region in gp120 oligomerization. Seddiki N; Bouhlal H; Rabehi L; Benjouad A; Devaux C; Gluckman JC; Gattegno L Biochim Biophys Acta; 1997 Jul; 1340(2):277-82. PubMed ID: 9252114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]